Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection
Condition: Safety Issues Intervention: Drug: Tenofovir Alafenamide 25 MG Sponsor: Taichung Veterans General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2022 Category: Research Source Type: clinical trials